Neoplasms - France, Research Site | Clinical Trial Radar

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Showing clinical trials for Neoplasms matching location: France, Research Site. I can help you find clinical trials in specific locations and provide insights on health conditions and treatments. With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

Showing clinical trials for Neoplasms matching location: France, Research Site.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

Study Title	Status
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (MEDIOLA) NCT02734004	Active, not recruitingResults Posted
Observational Study Protocol: LIVER-R NCT06252753	Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) NCT07044336	Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies. (TITANium) NCT06542250	Recruiting
Durvalumab and Tremelimumab for Pediatric Malignancies NCT03837899	Active, not recruitingResults Posted
REBECCA Real-world Early BrEast CanCer mAnagement NCT06856343	Recruiting
Anifrolumab Malignancy and Serious Infections Study (SIMA) NCT07000110	Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2) NCT06960577	Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma NCT07129993	Recruiting
PRostate Olaparib Real World Evidence Study (PROWESs) NCT06031805	Recruiting
Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations (POSITHES) NCT05103605	Active, not recruiting
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) NCT03875235	Active, not recruitingResults Posted
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors NCT06973161	Recruiting
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) NCT05555732	Active, not recruiting
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer NCT04592913	Active, not recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors NCT07015697	Recruiting
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors NCT03530397	Active, not recruiting
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance NCT06726720	Recruiting
First in Human Study of AZD9592 in Solid Tumors (EGRET) NCT05647122	Recruiting
A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer. (ARSENAL) NCT05683977	Active, not recruiting
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers NCT03212404	Active, not recruiting
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors NCT02671435	Active, not recruitingResults Posted
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies. (PRIMAVERA) NCT06137144	Recruiting
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) (TOURMALINE) NCT05771480	Active, not recruiting
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC (CAPItello-290) NCT03997123	Active, not recruiting
National Acalabrutinib Observational Study (NAOS) NCT05437250	Active, not recruiting
Savolitinib vs. Sunitinib in MET-driven PRCC. NCT03091192	Active, not recruitingResults Posted
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer (TB06) NCT07205822	Recruiting
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE) NCT05925530	Active, not recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors NCT06533059	Recruiting
COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC NCT04068610	Active, not recruitingResults Posted
A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors (PRIMROSE) NCT06130553	Recruiting
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations (DPT01) NCT04639219	Active, not recruitingResults Posted
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) NCT05489211	Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (CANTOR) NCT06792695	Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer (SEACLIFF) NCT07181161	Recruiting
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer (BISCAY) NCT02546661	Active, not recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies (Soundtrack-E) NCT06564038	Recruiting
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer NCT04931654	Active, not recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation (EvoPAR-PR02) NCT06952803	Recruiting
PASS of Paediatric Patients Initiating Selumetinib NCT05388370	Active, not recruiting
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents NCT02264678	Active, not recruiting
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) (CAPItello280) NCT05348577	Active, not recruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED) NCT05663515	Recruiting
A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition (MONETTE) NCT05061134	Active, not recruitingResults Posted
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O) NCT04421963	Active, not recruiting
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma NCT02213926	Active, not recruitingResults Posted
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) NCT07218809	Recruiting
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors NCT06005493	Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1) NCT05774951	Recruiting

Clinical Trial Radar

Phase

Type

Study Type

Age Group

Biological Sex